WHEN Becki Ward tried but failed to lose weight even after turning to fat jabs, she blamed sheer laziness. After years of ...
In a new video, social media star Aishwarya Mohanraj has opened up about her weight loss journey with Mounjaro. Social media users are appreciating her for being honest.
With generic weight-loss drugs set to arrive soon, marketers walk a tightrope between disease awareness and cosmetic allure ...
LLY posts 45% revenue growth to $65.2B in 2025 as GLP-1 drugs power results, and guides $80-$83B in sales with EPS up over 40 ...
Dr Reddy’s plans to launch generic semaglutide in March 2026, potentially lowering prices in India’s fast-growing weight-loss ...
Social media ads for prescription-only weight-loss medicines banned - The posts used discount codes and referral links to ...
Eli Lilly is flying high thanks to its success in the GLP-1 space, but what comes next?
Watchdog bans social media ads sharing discount codes for weight loss jabs - Social media posts were found to promote the ...
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for ...
Eli Lilly ( LLY 1.41%) has already scored major accomplishments in the GLP-1 boom. The company has delivered double-digit ...
Sagging, deflation, and hollowing are some of the unofficial side effects of GLP-1s. Can skincare readdress the balance?
A $3.5 billion pharmaceutical investment could drastically change the market dynamic for one section of the Northeast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results